Free Trial

Moderna (MRNA) SEC Filings & 10K Form

Moderna logo
$41.04 +0.32 (+0.79%)
Closing price 04:00 PM Eastern
Extended Trading
$41.14 +0.10 (+0.24%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Moderna SEC Filings

DateFilerForm TypeView
01/13/2025
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:38 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
2:18 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
3:51 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:55 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
2:23 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:26 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:15 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:19 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
2:49 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:54 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:35 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
3:19 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
7:49 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
7:52 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:15 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
2:29 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
4:42 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:26 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
2:42 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:34 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:37 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:45 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:30 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:33 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:02 PM
Moderna (Issuer)
Rubenstein David M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:19 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
6:05 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:23 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
10:44 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:19 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:34 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:28 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The Shadow President? (Ad)

President Trump has already launched a "shock and awe" flurry of new Executive Orders... He's withdrawn from the World Health Organization... exited the Paris climate accord... and begun dismantling many Federal programs... But there's ONE executive order that could go down in history as the most important of all.

It's likely just the start of a MUCH more radical move.
06/28/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:19 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/21/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:28 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
11:45 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:41 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:26 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
2:16 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
4:27 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
4:20 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
2:36 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
2:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
2:11 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:36 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:34 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:12 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
2:12 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
2:14 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
2:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
2:22 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
2:21 PM
Mock James M (Reporting)
Mock James M (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
2:21 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:27 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:23 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
12:41 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
3:03 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:43 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
3:24 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:51 PM
LANGER ROBERT (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:54 PM
Horning Sandra (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:57 PM
Moderna (Issuer)
Tallett Elizabeth E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:59 PM
Moderna (Issuer)
SAGAN PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:02 PM
Moderna (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:42 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:21 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:17 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:23 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Urgent Bitcoin alert for RIGHT NOW (Ad)

Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”

So please… click here to watch now.
04/15/2024
9:58 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
1:03 PM
Moderna (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
04/09/2024
3:09 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
2:32 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRNA) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners